Sign In
Buy CNSP
$5.24
+0.320 (+6.50%)
At Close: Jun 03, 2026
C'ttee has concluded work on new CVFF framework, says NIMASA boss
03:57am, Wednesday, 24'th Jun 2020
IN a bid to improve the accessibility of the Cabotage Vessel Financing Fund, CVFF, the Federal Government is set to roll out a new framew
Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020
12:49pm, Tuesday, 23'rd Jun 2020
NEW YORK, June 23, 2020 -- Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry.
CNS To Present at the Life Sciences Investor Forum
12:00pm, Tuesday, 23'rd Jun 2020
CNS Pharmaceuticals, Inc., (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and
Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Development of Over-the-Counter Opioid Overdose Reversal Medication
12:00am, Tuesday, 23'rd Jun 2020
Purdue Pharma L.P. and Harm Reduction Therapeutics, Inc. (HRT) announced today that Purdue will provide up to $6.5 million of additional financial sup
Coronavirus: la pandémie s’accélère sur le continent américain, nouvel épicentre
08:04pm, Monday, 22'nd Jun 2020
L’ouverture des frontières, la perspective des vacances, le relâchement des restrictions donnent le sentiment aux Européens que le pire est derrière eux.
Résultats de fin d'année: des abus dans certains conseils de classe déjà dénoncés
02:46pm, Monday, 22'nd Jun 2020
Alors que les premiers résultats sont communiqués par les conseils de classe aux parents des élèves de l'enseignement secondaire, les associations de première ligne tirent la sonnette d'alarme co
WPD Pharmaceuticals : Licensor Announces Confirmatory in Vitro Analysis of WP1122 | MarketScreener
11:01am, Monday, 22'nd Jun 2020CNS Pharmaceuticals Inc (NASDAQ:CNSP) Sees Significant Growth in Short Interest
06:16am, Sunday, 21'st Jun 2020
CNS Pharmaceuticals Inc (NASDAQ:CNSP) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 99,500 shares, an increase of 22.4% from the May
Molenbeek : Le PTB et l'IEB veulent une plus grande transparence dans les projets urbanistiques
05:44pm, Wednesday, 17'th Jun 2020
Inter-Environnement déplore aussi ce manque de transparence. Le parti d'extrême gauche introduira une motion ce soir en conseil communal.
Marc Princen appointed new Global CEO for Mundipharma
07:00am, Monday, 15'th Jun 2020
CAMBRIDGE, England — FOR MEDICAL BUSINESS/TRADE MEDIA ONLY Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently associated companies as the Global…
Marc Princen appointed new Global CEO for Mundipharma
12:00am, Monday, 15'th Jun 2020
FOR MEDICAL BUSINESS/TRADE MEDIA ONLY Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently associated com
Cortexyme: A New Approach To Defeat Alzheimer's Disease (NASDAQ:CRTX)
07:14pm, Friday, 12'th Jun 2020
Alzheimer's disease remains an unbreakable wall for biotech companies for decades. The recent fails in beta-amyloid thesis create an opportunity for better unde
Les représentants du monde de la nuit se disent ignorés des pouvoirs publics. Ils évoquent avec colère le silence et le mépris des politiques auxquels ils sont confrontés et sont toujours dans l
Federal government funds Victoria's Indigenous custody service
02:00pm, Friday, 12'th Jun 2020
A lifesaving service designed to prevent Indigenous deaths in custody in Victoria will receive $2.1 million in federal government funding.
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
12:00pm, Thursday, 11'th Jun 2020
CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and
